- Home
- OGI vs IPSC Comparison
OGI vs IPSC Comparison
Compare OGI & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OGI | IPSC |
|---|---|---|
| Founded | 2013 | 2019 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 218.5M | 58.3M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | OGI | IPSC |
|---|---|---|
| Price | $1.68 | $1.21 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | ★ 1.9M | 1.5M |
| Earning Date | 02-10-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $186,075,713.00 | $113,337,000.00 |
| Revenue This Year | $20.38 | $1,590.09 |
| Revenue Next Year | $6.02 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 4122.69 |
| 52 Week Low | $0.85 | $0.34 |
| 52 Week High | $2.24 | $1.19 |
Technical Indicators
Market Signals| Indicator | OGI | IPSC |
|---|---|---|
| Relative Strength Index (RSI) | 46.09 | 75.06 |
| Support Level | $1.67 | $0.90 |
| Resistance Level | $1.76 | $1.05 |
| Average True Range (ATR) | 0.13 | 0.14 |
| MACD | -0.03 | 0.02 |
| Stochastic Oscillator | 12.50 | 96.66 |
Price Performance
Historical ComparisonAbout OGI Organigram Holdings Inc.
Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.
About IPSC Century Therapeutics Inc.
Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.